Molina's Q3 Net Income Plunges 76% Amid Soaring Medical Costs
Ticker: MOH · Form: 10-Q · Filed: Oct 23, 2025 · CIK: 1179929
| Field | Detail |
|---|---|
| Company | Molina Healthcare, Inc. (MOH) |
| Form Type | 10-Q |
| Filed Date | Oct 23, 2025 |
| Risk Level | high |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: Healthcare, Managed Care, Medicaid, Medicare, Earnings Miss, Medical Costs, Profitability Decline
Related Tickers: MOH, UNH, ELV, CNC
TL;DR
**MOH's Q3 earnings are a disaster, with medical costs eating into revenue and crushing profits; time to re-evaluate your position.**
AI Summary
Molina Healthcare, Inc. (MOH) reported a significant decline in net income for the three and nine months ended September 30, 2025, despite an increase in total revenue. For the three months, net income plummeted 75.77% to $79 million from $326 million in the prior year, while diluted EPS fell to $1.51 from $5.65. Over nine months, net income decreased 31.90% to $632 million from $928 million, with diluted EPS dropping to $11.79 from $15.97. Total revenue for the three months increased 11.00% to $11,477 million, driven by a 11.83% rise in premium revenue to $10,841 million. However, medical care costs surged 16.21% to $10,044 million, outpacing revenue growth. Operating income for the three months fell sharply by 70.66% to $137 million from $467 million. The company also saw a substantial increase in long-term debt, rising to $3,664 million at September 30, 2025, from $2,923 million at December 31, 2024, and engaged in $1,000 million in common stock purchases during the nine months ended September 30, 2025. Cash and cash equivalents decreased to $4,221 million from $4,662 million since year-end 2024.
Why It Matters
Molina's sharp decline in net income, despite revenue growth, signals significant pressure on profitability due to rising medical care costs. This trend could impact investor confidence, potentially leading to stock price volatility as the market re-evaluates MOH's earnings power and operational efficiency. For employees, sustained profitability challenges could affect future compensation or job security, while customers might face increased premiums or reduced benefits if the company struggles to manage costs. In the competitive healthcare market, Molina's peers like UnitedHealth Group or Elevance Health, which may be better at cost containment, could gain market share or pricing power, intensifying competitive pressures on MOH.
Risk Assessment
Risk Level: high — The company's net income for the three months ended September 30, 2025, decreased by 75.77% to $79 million from $326 million in the prior year, primarily due to a 16.21% increase in medical care costs to $10,044 million, significantly outpacing the 11.00% revenue growth. This substantial erosion of profitability, coupled with a 25.35% increase in long-term debt to $3,664 million since December 31, 2024, indicates heightened financial risk.
Analyst Insight
Investors should consider reducing exposure to MOH given the severe profit decline and rising medical costs. Monitor future filings closely for any signs of improved cost management or a reversal in the negative earnings trend before considering new investments.
Financial Highlights
- debt To Equity
- N/A
- revenue
- $11,477 million
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- $3,664 million
- net Income
- $79 million
- eps
- $1.51
- gross Margin
- N/A
- cash Position
- $4,221 million
- revenue Growth
- +11.00%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Medicaid | $10,841 million | +11.83% |
| Medicare | N/A | N/A |
| Marketplace | N/A | N/A |
| Other | N/A | N/A |
Key Numbers
- $79M — Net Income (Q3 2025) (75.77% decrease from $326M in Q3 2024)
- $11.48B — Total Revenue (Q3 2025) (11.00% increase from $10.34B in Q3 2024)
- $10.04B — Medical Care Costs (Q3 2025) (16.21% increase from $8.64B in Q3 2024)
- $1.51 — Diluted EPS (Q3 2025) (73.27% decrease from $5.65 in Q3 2024)
- $137M — Operating Income (Q3 2025) (70.66% decrease from $467M in Q3 2024)
- $3.66B — Long-term Debt (Sep 30, 2025) (25.35% increase from $2.92B at Dec 31, 2024)
- 51 million — Shares Outstanding (Oct 17, 2025) (Decreased from 56 million at Dec 31, 2024 due to buybacks)
- $1,000M — Common Stock Purchases (9M 2025) (Significant capital allocation to share repurchases)
- $4.22B — Cash and Cash Equivalents (Sep 30, 2025) (Decreased from $4.66B at Dec 31, 2024)
- 5.6 million — Members Served (Sep 30, 2025) (Indicates scale of operations across 21 states)
Key Players & Entities
- MOLINA HEALTHCARE, INC. (company) — registrant
- Centers for Medicare and Medicaid Services (regulator) — contracting agency for Medicare and Marketplace
- Financial Accounting Standards Board (regulator) — issued ASU 2025-06
- $79 million (dollar_amount) — Net income for three months ended September 30, 2025
- $326 million (dollar_amount) — Net income for three months ended September 30, 2024
- $11,477 million (dollar_amount) — Total revenue for three months ended September 30, 2025
- $10,044 million (dollar_amount) — Medical care costs for three months ended September 30, 2025
- $3,664 million (dollar_amount) — Long-term debt at September 30, 2025
- $1,000 million (dollar_amount) — Common stock purchases for nine months ended September 30, 2025
- 5.6 million (dollar_amount) — Members served as of September 30, 2025
FAQ
Why did Molina Healthcare's net income decrease so significantly in Q3 2025?
Molina Healthcare's net income decreased by 75.77% to $79 million in Q3 2025 primarily because medical care costs surged by 16.21% to $10,044 million, outpacing the 11.00% increase in total revenue to $11,477 million.
What were Molina Healthcare's total revenues for the three months ended September 30, 2025?
Molina Healthcare reported total revenues of $11,477 million for the three months ended September 30, 2025, an 11.00% increase compared to $10,340 million in the same period of 2024.
How did Molina Healthcare's medical care costs change in Q3 2025?
Medical care costs for Molina Healthcare increased significantly by 16.21% to $10,044 million for the three months ended September 30, 2025, up from $8,643 million in the prior year period.
What is Molina Healthcare's current long-term debt as of September 30, 2025?
As of September 30, 2025, Molina Healthcare's long-term debt stood at $3,664 million, an increase from $2,923 million at December 31, 2024.
How many members does Molina Healthcare serve?
As of September 30, 2025, Molina Healthcare served approximately 5.6 million members across 21 states, participating in government-sponsored healthcare programs.
What is the impact of the Minimum MLR on Molina Healthcare's revenue?
The Minimum MLR (Medical Loss Ratio) provisions, such as 85% for Medicare and 80% for Marketplace, require Molina Healthcare to return a portion of premium revenue as rebates if defined medical care cost thresholds are not met. For example, the company recorded a liability of $38 million for Medicare and $18 million for Marketplace at September 30, 2025, for potential rebates.
What are the key risks for Molina Healthcare's state Medicaid contracts?
Molina Healthcare's state Medicaid contracts, typically 3-5 years, are subject to competitive bidding through RFPs. There is a risk of non-renewal if the company is not a successful bidder, and contracts can be amended to include or exclude certain benefits, populations, or service areas.
Did Molina Healthcare engage in any share repurchases?
Yes, Molina Healthcare engaged in common stock purchases totaling $1,000 million for the nine months ended September 30, 2025, reducing outstanding shares from 56 million at December 31, 2024, to 51 million at October 17, 2025.
What is the purpose of the Marketplace risk adjustment program for Molina Healthcare?
The Marketplace risk adjustment program compares Molina Healthcare's composite risk scores with the overall average for the relevant state and market pool. This program results in either a payment into the pool (if scores are below average) or a payment from the pool (if scores are above average), adjusting premium revenue. As of September 30, 2025, Molina had a net payable of $170 million for this program.
What is the outlook for Molina Healthcare's full-year results based on this 10-Q?
The consolidated results for the nine months ended September 30, 2025, with net income down 31.90% to $632 million, are not necessarily indicative of the entire year. However, the significant decline in Q3 net income and rising medical costs suggest potential challenges for achieving strong full-year profitability compared to the prior year.
Risk Factors
- Contract Renewal Uncertainty [high — regulatory]: Molina's state Medicaid contracts have terms of three to five years with renewal options exercisable by the state. These contracts are subject to competitive bidding through RFPs, and failure to be a successful bidder could result in non-renewal, posing a significant risk to revenue streams.
- Contract Amendments and Benefit Changes [medium — regulatory]: State Medicaid contracts can be amended to include or exclude specific health benefits, populations (e.g., ABD), or service areas. Such changes can impact the scope of services offered and potentially alter profitability.
- Annual Medicare Contract Renewals [medium — regulatory]: Medicare Advantage-Part D contracts with CMS are renewed annually, creating a recurring need for successful contract negotiation and compliance. This annual renewal process introduces a degree of uncertainty each year.
- Marketplace Contract Renewals [medium — regulatory]: Marketplace contracts with CMS also require annual renewal, ending on December 31st each year. This necessitates continuous engagement and compliance to maintain market presence.
- Rising Medical Care Costs [high — financial]: Medical care costs surged 16.21% to $10,044 million in Q3 2025, outpacing the 11.00% increase in total revenue. This significant cost pressure directly impacts profitability, as evidenced by the sharp decline in operating income.
- Increased Long-Term Debt [medium — financial]: Long-term debt increased to $3,664 million as of September 30, 2025, from $2,923 million at the end of 2024, a 25.35% rise. This increased leverage could heighten financial risk, especially if profitability does not recover.
- Share Repurchases and Cash Position [medium — financial]: The company spent $1,000 million on common stock purchases in the first nine months of 2025, contributing to a decrease in cash and cash equivalents to $4,221 million from $4,662 million at year-end 2024. This capital allocation strategy reduces liquidity.
- Scale of Operations and State Dependence [medium — operational]: Serving approximately 5.6 million members across 21 states highlights the company's scale. However, this also means significant dependence on the regulatory and economic conditions within each of these states.
Industry Context
Molina Healthcare operates within the highly regulated managed healthcare sector, primarily serving government-sponsored programs like Medicaid and Medicare. The industry is characterized by intense competition, reliance on government contracts, and significant regulatory oversight. Trends include increasing healthcare costs, evolving benefit mandates, and a push towards value-based care, all of which impact profitability and operational strategies.
Regulatory Implications
Molina's business is heavily dependent on government contracts (Medicaid, Medicare, Marketplace) which are subject to annual or multi-year renewals and can be amended by states. The competitive bidding process for these contracts, particularly for Medicaid, presents a constant risk of non-renewal. Compliance with evolving regulations from CMS and state agencies is critical for continued operation and profitability.
What Investors Should Do
- Monitor Medical Cost Trends
- Assess Contract Renewal Risks
- Evaluate Capital Allocation Strategy
- Analyze Margin Compression
Key Dates
- 2025-09-30: End of Third Quarter and Nine Months — Reporting period for the 10-Q, showing significant net income decline despite revenue growth and increased medical costs.
- 2025-12-31: Previous Fiscal Year End — Baseline for comparison of debt and cash positions, showing an increase in debt and decrease in cash.
- 2025-10-17: Common Stock Outstanding Date — Indicates a reduction in shares outstanding from 56 million to 51 million due to buybacks.
Glossary
- Marketplace
- Refers to the state insurance marketplaces established under the Affordable Care Act where individuals can purchase health insurance. (Molina operates in these marketplaces, and contracts are renewed annually.)
- ABD
- Aged, Blind, or Disabled. Refers to specific populations that can be included or excluded from Medicaid contracts. (Changes in coverage for ABD populations can impact Molina's business and profitability.)
- RFP
- Request for Proposal. A document that outlines an organization's needs and invites potential vendors to submit proposals to meet those needs. (Molina's state Medicaid contracts are subject to competitive bidding via RFPs, posing a risk of non-renewal.)
- CMS
- Centers for Medicare and Medicaid Services. A federal agency that administers Medicare, Medicaid, and the Children's Health Insurance Program. (Molina contracts with CMS for Medicare and Marketplace programs, requiring annual renewals.)
- Premium Revenue
- The revenue generated from insurance premiums paid by members or government entities for health coverage. (This is the primary revenue driver for Molina, and its growth is crucial for covering costs.)
- Medical Care Costs
- The expenses incurred by the health plan for providing healthcare services to its members. (A significant cost driver for Molina; rapid increases can severely impact profitability.)
Year-Over-Year Comparison
Compared to the prior year, Molina Healthcare experienced a substantial decline in profitability, with net income for Q3 2025 plummeting 75.77% to $79 million and diluted EPS falling to $1.51. This occurred despite an 11.00% increase in total revenue, driven by premium revenue growth. However, medical care costs surged 16.21%, significantly outpacing revenue, leading to a sharp 70.66% decrease in operating income. Long-term debt has also increased by 25.35% since year-end 2024, while cash reserves have decreased, indicating a tightening financial position.
Filing Stats: 4,724 words · 19 min read · ~16 pages · Grade level 13.9 · Accepted 2025-10-23 10:08:55
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 Par Value MOH New York Stock Exchange
Filing Documents
- moh-20250930.htm (10-Q) — 1305KB
- molina-restrictedstockaw.htm (EX-10.1) — 56KB
- molina-performancestocku.htm (EX-10.2) — 61KB
- moh3q25_ex311.htm (EX-31.1) — 9KB
- moh3q25_ex312.htm (EX-31.2) — 9KB
- moh3q25_ex321.htm (EX-32.1) — 5KB
- moh3q25_ex322.htm (EX-32.2) — 5KB
- moh-20250930_g1.jpg (GRAPHIC) — 22KB
- molina-performancestocku001.jpg (GRAPHIC) — 180KB
- molina-performancestocku002.jpg (GRAPHIC) — 246KB
- molina-performancestocku003.jpg (GRAPHIC) — 297KB
- molina-performancestocku004.jpg (GRAPHIC) — 299KB
- molina-performancestocku005.jpg (GRAPHIC) — 298KB
- molina-performancestocku006.jpg (GRAPHIC) — 307KB
- molina-performancestocku007.jpg (GRAPHIC) — 321KB
- molina-performancestocku008.jpg (GRAPHIC) — 297KB
- molina-performancestocku009.jpg (GRAPHIC) — 261KB
- molina-performancestocku010.jpg (GRAPHIC) — 63KB
- molina-performancestocku011.jpg (GRAPHIC) — 27KB
- molina-performancestocku012.jpg (GRAPHIC) — 252KB
- molina-performancestocku013.jpg (GRAPHIC) — 270KB
- molina-performancestocku014.jpg (GRAPHIC) — 207KB
- molina-performancestocku015.jpg (GRAPHIC) — 42KB
- molina-restrictedstockaw001.jpg (GRAPHIC) — 248KB
- molina-restrictedstockaw002.jpg (GRAPHIC) — 315KB
- molina-restrictedstockaw003.jpg (GRAPHIC) — 287KB
- molina-restrictedstockaw004.jpg (GRAPHIC) — 320KB
- molina-restrictedstockaw005.jpg (GRAPHIC) — 308KB
- molina-restrictedstockaw006.jpg (GRAPHIC) — 318KB
- molina-restrictedstockaw007.jpg (GRAPHIC) — 283KB
- molina-restrictedstockaw008.jpg (GRAPHIC) — 285KB
- molina-restrictedstockaw009.jpg (GRAPHIC) — 235KB
- molina-restrictedstockaw010.jpg (GRAPHIC) — 59KB
- molina-restrictedstockaw011.jpg (GRAPHIC) — 41KB
- molina-restrictedstockaw012.jpg (GRAPHIC) — 275KB
- molina-restrictedstockaw013.jpg (GRAPHIC) — 278KB
- molina-restrictedstockaw014.jpg (GRAPHIC) — 251KB
- molina-restrictedstockaw015.jpg (GRAPHIC) — 35KB
- molina-restrictedstockaw016.jpg (GRAPHIC) — 46KB
- 0001179929-25-000128.txt ( ) — 16879KB
- moh-20250930.xsd (EX-101.SCH) — 38KB
- moh-20250930_cal.xml (EX-101.CAL) — 74KB
- moh-20250930_def.xml (EX-101.DEF) — 164KB
- moh-20250930_lab.xml (EX-101.LAB) — 531KB
- moh-20250930_pre.xml (EX-101.PRE) — 362KB
- moh-20250930_htm.xml (XML) — 1326KB
Signatures
Signatures 37 Table of Contents CONSOLIDATED STATEMENTS OF INCOME Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 (In millions, except per-share amounts) (Unaudited) Revenue: Premium revenue $ 10,841 $ 9,694 $ 32,337 $ 28,644 Premium tax revenue 506 508 1,325 1,103 Investment income 108 118 322 341 Other revenue 22 20 67 63 Total revenue 11,477 10,340 34,051 30,151 Operating expenses: Medical care costs 10,044 8,643 29,352 25,425 General and administrative expenses 729 676 2,214 2,078 Premium tax expenses 506 508 1,325 1,103 Depreciation and amortization 45 47 151 138 Other 16 ( 1 ) 66 80 Total operating expenses 11,340 9,873 33,108 28,824 Operating income 137 467 943 1,327 Interest expense 49 29 140 84 Income before income tax expense 88 438 803 1,243 Income tax expense 9 112 171 315 Net income $ 79 $ 326 $ 632 $ 928 Net income per share - Basic $ 1.51 $ 5.67 $ 11.81 $ 16.05 Net income per share - Diluted $ 1.51 $ 5.65 $ 11.79 $ 15.97 CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 (In millions) (Unaudited) Net income $ 79 $ 326 $ 632 $ 928 Other comprehensive gain: Unrealized investment gain 25 100 87 96 Less: effect of income taxes 6 24 21 23 Other comprehensive gain, net of tax 19 76 66 73 Comprehensive income $ 98 $ 402 $ 698 $ 1,001 See accompanying notes. Molina Healthcare, Inc. September 30, 2025 Form 10-Q | 3 Table of Contents CONSOLIDATED BALANCE SHEETS September 30, 2025 December 31, 2024 (Dollars in millions, except per-share amounts) (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 4,221 $ 4,662 Investments 4,226 4,325 Receivables 3,515 3,299 Prepaid expenses and other current assets 590 487 Total current assets 12,552 12,773 Property, equipment, and capitalized software, net 323 288 Goodwill, and intangible assets, net 2,202 1,938 Restricted investm
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) SEPTEMBER 30, 2025 1. Organization and Basis of Presentation Organization and Operations Molina Healthcare, Inc. provides managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces (the "Marketplace"). We currently have four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. As of September 30, 2025, we served approximately 5.6 million members eligible for government-sponsored healthcare programs, located across 21 states. Our state Medicaid contracts typically have terms of three years to five years , contain renewal options exercisable by the state Medicaid agency, and allow either the state or the health plan to terminate the contract with or without cause. Such contracts are subject to risk of loss in states that issue requests for proposal ("RFP") open to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may not be renewed. In addition to contract renewal, our state Medicaid contracts may be periodically amended to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations such as the aged, blind or disabled ("ABD"); and regions or service areas. In Medicare, we enter into Medicare Advantage-Part D contracts with the Centers for Medicare and Medicaid Services ("CMS") annually, and for dual-eligible programs, we enter into contracts with CMS, in partnership with each state's department of health and human services. Such contracts typically have terms of one year to three years . In Marketplace, we enter into contracts with CMS, which end on December 31 of each year, and must be renewed annually. Consolidation and Interim Financi